BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38232565)

  • 1. Treatment of patients with screen-detected colorectal cancer is less strenuous: a nationwide cohort study with long-term follow-up.
    Dressler J; Njor SH; Rasmussen M; Jørgensen LN
    Public Health; 2024 Feb; 227():169-175. PubMed ID: 38232565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Less Invasive Primary Treatment for Colorectal Cancer After Implementation of National Screening: A Nationwide Cohort Study.
    Dressler J; Njor SH; Jørgensen LN; Rasmussen M
    World J Surg; 2023 Nov; 47(11):2877-2887. PubMed ID: 37610467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative Outcomes of Screen-Detected vs Non-Screen-Detected Colorectal Cancer in the Netherlands.
    de Neree Tot Babberich MPM; Vermeer NCA; Wouters MWJM; van Grevenstein WMU; Peeters KCMJ; Dekker E; Tanis PJ;
    JAMA Surg; 2018 Dec; 153(12):e183567. PubMed ID: 30285063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
    Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
    J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Recurrence and Time to Recurrence in Stage I to III Colorectal Cancer: A Nationwide Danish Cohort Study.
    Nors J; Iversen LH; Erichsen R; Gotschalck KA; Andersen CL
    JAMA Oncol; 2024 Jan; 10(1):54-62. PubMed ID: 37971197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization.
    Chastek B; Kulakodlu M; Valluri S; Seal B
    Postgrad Med; 2013 Mar; 125(2):73-82. PubMed ID: 23816773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More Favorable Short and Long-Term Outcomes for Screen-Detected Colorectal Cancer Patients.
    Spolverato G; Capelli G; Battagello J; Barina A; Nordio S; Finotti E; Mondi I; Da Lio C; Morpurgo E; Navarro JA; Ceccato F; Perin A; Pedrazzani C; Turri G; Zanus G; Campi M; Massani M; Di Giacomo A; Prando D; Agresta F; Pucciarelli S; Zorzi M; Rugge M
    Front Oncol; 2021; 11():620644. PubMed ID: 33791207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer mortality after randomized implementation of FIT-based screening - a nationwide cohort study.
    Njor SH; Larsen MB; Søborg B; Andersen B
    J Med Screen; 2022 Dec; 29(4):241-248. PubMed ID: 35635233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
    Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
    World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
    Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
    Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of lower gastrointestinal bleeding and colorectal neoplasms following initiation of low-dose aspirin: a Danish population-based cohort study.
    Troelsen FS; Farkas DK; Erichsen R; Sørensen HT
    BMJ Open Gastroenterol; 2020 Jul; 7(1):. PubMed ID: 32719046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of colorectal cancer screening on colorectal cancer surgery outcomes: nationwide cohort study.
    Dressler J; Njor SH; Rasmussen M; Jørgensen LN
    BJS Open; 2024 Mar; 8(2):. PubMed ID: 38502539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort.
    Bjerrum A; Milter MC; Andersen O; Fischer A; Lynge E
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1433-7. PubMed ID: 26352132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations.
    Atkin W; Brenner A; Martin J; Wooldrage K; Shah U; Lucas F; Greliak P; Pack K; Kralj-Hans I; Thomson A; Perera S; Wood J; Miles A; Wardle J; Kearns B; Tappenden P; Myles J; Veitch A; Duffy SW
    Health Technol Assess; 2017 Apr; 21(25):1-536. PubMed ID: 28621643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death.
    Doubeni CA; Fedewa SA; Levin TR; Jensen CD; Saia C; Zebrowski AM; Quinn VP; Rendle KA; Zauber AG; Becerra-Culqui TA; Mehta SJ; Fletcher RH; Schottinger J; Corley DA
    Gastroenterology; 2019 Jan; 156(1):63-74.e6. PubMed ID: 30268788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with mode of colorectal cancer detection and time to diagnosis: a population level study.
    Sikdar KC; Dickinson J; Winget M
    BMC Health Serv Res; 2017 Jan; 17(1):7. PubMed ID: 28056946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.